Immatics (IMTX) Interest & Investment Income (2019 - 2025)
Immatics recorded quarterly Interest & Investment Income of $37.4 million in Q4 2025, up 653.11% quarter-over-quarter from $5.0 million in Q3 2025, and up 613.74% year-over-year from $5.2 million in Q4 2024.
Immatics' Interest & Investment Income history runs 7 years deep, the most recent figure standing at $37.4 million for Q4 2025.
- In Q4 2025, Interest & Investment Income rose 613.74% year-over-year to $37.4 million; the TTM figure through Dec 2025 stood at $41.6 million (up 89.67% YoY), while the FY2025 annual figure was $20.9 million, up 178.3% from the prior year.
- Interest & Investment Income came in at $37.4 million for Q4 2025 at Immatics, up from $5.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $37.4 million in Q4 2025 to a low of -$7.3 million in Q4 2024.
- A 5-year average of $6.6 million and a median of $5.7 million in 2025 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 44781.58% in 2022 and plunged 35826.69% in 2023, its largest moves.
- Immatics' Interest & Investment Income stood at $6.6 million in 2021, then surged by 54.72% to $10.2 million in 2022, then soared by 140.37% to $24.6 million in 2023, then tumbled by 129.63% to -$7.3 million in 2024, then jumped by 613.74% to $37.4 million in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $37.4 million, $5.0 million, and $5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 37.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.42 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 5.00 Mn |
| Mar 31, 2025 | -5.75 Mn |
| Dec 31, 2024 | -7.28 Mn |
| Sep 30, 2024 | 6.47 Mn |
| Jun 30, 2024 | 10.41 Mn |
| Mar 31, 2024 | 12.36 Mn |
| Dec 31, 2023 | 24.58 Mn |
| Sep 30, 2023 | 10.61 Mn |
| Jun 30, 2023 | 4.31 Mn |
| Mar 31, 2023 | -2.42 Mn |
| Dec 31, 2022 | 10.22 Mn |
| Sep 30, 2022 | 7.90 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Mar 31, 2022 | -6,734.03 |
| Dec 31, 2021 | 6.61 Mn |
| Sep 30, 2021 | -17,689.31 |
| Jun 30, 2021 | -45,762.31 |
| Mar 31, 2021 | -59,105.57 |
| Dec 31, 2020 | 264,688.35 |
| Sep 30, 2020 | -370,280.48 |
| Jun 30, 2020 | -480,236.62 |
| Mar 31, 2020 | -352,156.55 |
| Dec 31, 2019 | -388,517.57 |
| Sep 30, 2019 | -208,080.52 |